Physiomics PLC - Oxfordshire, England-based mathematical modelling company focused on aiding development of new therapeutics - Reports new contract with "valued and long-standing client" Numab ...

The global recombinant proteins market size was US$ 1.5 billion in 2021. The global recombinant proteins market is forecasted to grow to US$ 4 billion by 2030 by registering a compound annual growth ...

Bengaluru-based Immuneel Therapeutics has secured a $150,000 G-Rex® Grant from ScaleReady to accelerate development of ...

What's driving the shift to spatially resolved molecular analysis? The global in situ hybridization market, valued at USD 1.64 billion ...

Asset Management One Co. Ltd. lifted its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 12.8% during the first quarter, according to its most recent disclosure with the Securities and ...

Shares of Bio-Techne Corp. TECH slipped 4.13% to $49.50 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.84% to 5,982.72 ...

Fintel reports that on May 30, 2025, Wells Fargo initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Overweight recommendation. Analyst Price Forecast Suggests 71.21% Upside As of May 6, 2025 ...

PR Newswire CAMBRIDGE, Mass. and MINNEAPOLIS, May 8, 2025 Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to expedite cell therapy manufacturing.

Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other products for research and said it is ...